Prevalence of metabolic syndrome in COPD patients and its consequences

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Breyer, Marie Kathrin ^a,b,c   Spruit, Martijn A ^b   Hanson, Corrine K ^d   Franssen, Frits M E ^b   Vanfleteren, Lowie E G W ^b   Groenen, Miriam T J ^b   Bruijnzeel, Piet L B ^e   Wouters, Emiel F M ^a,b   Rutten, Erica P A ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Center of Expertise for Chronic Organ Failure   (Netherlands)

^c OTTO WAGNER HOSPITAL   (Austria)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD GAS; BODY COMPOSITION; BODY MASS; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; COMORBIDITY; CONTROLLED STUDY; ERGOMETRY; EXERCISE TEST; FAT FREE MASS; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOOD; OBESITY; PEER GROUP; PREVALENCE; SELF REPORT; SEX DIFFERENCE; SPIROMETRY; AGED; BLOOD PRESSURE; COMPLICATION; EXERCISE; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR;

AGED; BLOOD PRESSURE; BODY MASS INDEX; BONE DENSITY; EXERCISE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84903376871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098013     Document Type: Article

References (33)

1. Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33: 1165-1185.
2. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, et al. (2006) Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 16: 63-70. (Pubitemid 41783891)
3. Mannino DM, Thorn D, Swensen A, Holguin F (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32: 962-969.
4. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, et al. (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 155-161.
5. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480.
6. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365: 1415-1428. (Pubitemid 40523737)
7. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689. (Pubitemid 32893993)
8. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama 288: 2709-2716. (Pubitemid 35403784)
9. Ribisl PM, Lang W, Jaramillo SA, Jakicic JM, Stewart KJ, et al. (2007) Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the Look AHEAD clinical trial. Diabetes Care 30: 2679-2684. (Pubitemid 47554229)
10. Ford ES, Li C (2006) Physical activity or fitness and the metabolic syndrome. Expert Rev Cardiovasc Ther 4: 897-915. (Pubitemid 46017526)
11. Kinjo M, Setoguchi S, Solomon DH (2007) Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J Clin Endocrinol Metab 92: 4161-4164. (Pubitemid 350074726)
12. Wells G (2013) Metabolic syndrome and diabetes mellitus in COPD: European Respiratory Monograph.
13. Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, et al. (2005) The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 25: 226-232; discussion 233-224.
14. Watz H, Waschki B, Kirsten A, Muller KC, Kretschmar G, et al. (2009) The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 136: 1039-1046.
15. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2013) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 187: 347-365.
16. Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145: 1321-1327.
17. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370. (Pubitemid 13098606)
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383. (Pubitemid 17055592)
19. van den Borst B, Gosker HR, Koster A, Yu B, Kritchevsky SB, et al. (2012) The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. Am J Clin Nutr 96: 516-526.
20. Leone N, Courbon D, Thomas F, Bean K, Jego B, et al. (2009) Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 179: 509-516.
21. Schols AM, Mostert R, Soeters PB, Wouters EF (1991) Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 46: 695-699.
22. Wong CY, O'Moore-Sullivan T, Fang ZY, Haluska B, Leano R, et al. (2005) Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 96: 1686-1691. (Pubitemid 41790392)
23. Yamaguchi T, Kanazawa I, Yamamoto M, Kurioka S, Yamauchi M, et al. (2009) Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone 45: 174-179.
24. Reid IR (2006) Obesity and osteoporosis. Ann Endocrinol (Paris) 67: 125-129.
25. Reid IR (2010) Fat and bone. Arch Biochem Biophys 503: 20-27.
26. Pobeha P, Ukropec J, Skyba P, Ukropcova B, Joppa P, et al. (2011) Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone 48: 1008-1014.
27. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, et al. (1997) Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 127: 1072-1079. (Pubitemid 28012076)
28. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, et al. (1996) Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 51: 39-43. (Pubitemid 26048724)
29. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, et al. (1998) Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 785-790.
30. Shoup R, Dalsky G, Warner S, Davies M, Connors M, et al. (1997) Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 10: 1576-1580. (Pubitemid 27311075)
31. Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, et al. (2007) Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 55: 374-382. (Pubitemid 46328104)
32. Tsai AG, Wadden TA, Sarwer DB, Berkowitz RI, Womble LG, et al. (2008) Metabolic syndrome and health-related quality of life in obese individuals seeking weight reduction. Obesity (Silver Spring) 16: 59-63. (Pubitemid 351271950)
33. Minas M, Kostikas K, Papaioannou AI, Mystridou P, Karetsi E, et al. (2011) The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD 8: 414-420.